Spotlight on Alexion's pricing of rare-disease drug Soliris

Josh DeBortoli

A special drug for an extremely rare disease, Soliris costs about half a million dollars per patient, per year, for life. Why? The reasons for the price are locked in "the black box" of drug pricing that governments are seeking to crack open.



from CBC | Health News http://ift.tt/1e4W1NP

Aucun commentaire:

Enregistrer un commentaire